4//SEC Filing
ICOS CORP 4
Accession 0001181431-07-006890
CIK 0000874294operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:17 PM ET
Size
7.8 KB
Accession
0001181431-07-006890
Insider Transaction Report
Form 4
ICOS CORPICOS
HERBOLD ROBERT J
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-01-29$11.60/sh−30,000$348,000→ 0 totalExercise: $22.40From: 2005-03-16Exp: 2015-03-16→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−7,000$238,000→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 7,000 shares of unvested restricted stock.
- [F2]Vests in two equal amounts as of each of the next two annual stockholders' meetings of the Issuer following the grant date indicated, assuming continued service on the Board of Directors.
Documents
Issuer
ICOS CORP
CIK 0000874294
Entity typeoperating
IncorporatedWA
Related Parties
1- filerCIK 0000874294
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 5:17 PM ET
- Size
- 7.8 KB